Inspira Technologies OXY B.H.N. (NASDAQ:IINN) Shares Up 15% – Should You Buy?

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)’s share price traded up 15% during trading on Friday. The stock traded as high as $0.87 and last traded at $0.7846. 12,688,557 shares were traded during trading, an increase of 3,500% from the average daily volume of 352,435 shares. The stock had previously closed at $0.6820.

Inspira Technologies OXY B.H.N. Stock Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.56 and a quick ratio of 1.30. The stock has a 50 day moving average price of $0.88 and a two-hundred day moving average price of $0.99.

Hedge Funds Weigh In On Inspira Technologies OXY B.H.N.

A hedge fund recently raised its stake in Inspira Technologies OXY B.H.N. stock. Yorkville Advisors Global LP raised its stake in shares of Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) by 10.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,977,724 shares of the company’s stock after buying an additional 193,880 shares during the quarter. Inspira Technologies OXY B.H.N. comprises 0.5% of Yorkville Advisors Global LP’s portfolio, making the stock its 18th biggest position. Yorkville Advisors Global LP owned 5.50% of Inspira Technologies OXY B.H.N. worth $883,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 12.72% of the company’s stock.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies OXY B.H.N. Ltd. is an Israel-based medical technology company focused on developing respiratory-care solutions for patients experiencing acute respiratory failure. The company’s technologies are designed to support blood oxygenation and carbon dioxide removal outside the lungs, with the goal of helping clinicians manage critically ill patients.

Its principal product platform is the INSPIRA ART (Augmented Respiratory Technology) system, an extracorporeal respiratory support technology intended to oxygenate blood and remove carbon dioxide without requiring a conventional heart-lung machine.